Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse

Bone Marrow Transplantation

Volumn 17, Issue 1, 1996, Pages 39-42

  Chiang, K Y ^a   Weisdorf, D J ^a   Davies, S M ^a   Enright, H ^a   Kersey, J H ^a   McGlave, P B ^a   Miller, W ^a   Ramsay, N K C ^a   Steinbuch, M ^a   Wagner, J E ^a   Blazar, B R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Relapse; Second BMT

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE COURSE; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HUMAN; LYMPHOMA; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RELAPSE; REOPERATION; SIBLING; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; RECURRENCE; SURVIVAL RATE; WHOLE-BODY IRRADIATION;

EID: 13344284643     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ramsay NKC. Bone marrow transplantation in pediatric oncology. In: Pizzo PA, Poplack DG (eds). Principles and Practice of Pediatric Oncology. JB Lippincott: Philadelphia, 1993, pp 315-334.
2. Gale RP, Kersey JH, Bortin MM et al. Bone marrow transplantation for acute lymphoblastic leukaemia. Lancet 1983; 2: 663-667.
3. Bostrom B, Woods WG, Nesbit ME et al. Successful reinduction of patients with acute lymphoblastic leukemia who relapse following bone marrow transplantation. J Clin Oncol 1987; 5: 376-381.
4. Barrett AJ, Joshi R, Tew C. How should acute lymphoblastic leukemia relapsing after bone marrow transplantation be treated? Lancet 1985; 1: 1188-1191.
5. Champlin RE, Ho WG, Lenarsky C et al. Successful second bone marrow transplants for treatment of acute myelogenous leukemia or acute lymphoblastic leukemia. Transplant Proc 1985; 17: 496-499.
6. Atkinson K, Biggs J, Dodds A et al. Second marrow transplants for recurrence of haematological malignancy. Bone Marrow Transplant 1986; 1: 159-166.
7. Blume KG, Forman SJ. High dose busulfan/etoposide as a preparatory regimen for second bone marrow transplants in hematologic malignancies. Blut 1987; 55: 49-53.
8. Marmont AM, van Lint MT, Frassoni F, Bacigalupo A. Second marrow transplants for relapsed leukaemia after allogeneic bone marrow transplantation. Bone Marrow Transplant 1988; 3 (suppl. 1): 332-333.
9. Barrett AJ, Locatelli F, Treleaven JG et al. Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukemia Working Party. Br J Haematol 1991; 79: 567-574.
10. Spinolo JA, Yau JC, Dicke KA et al. Second bone marrow transplants for relapsed leukemia. Cancer 1992; 69: 405-409.
11. Hashimoto S, Nakaseko T, Asai T et al. Second bone marrow transplantation for hematological malignancies. Exp Hematol 1992; 20: 715 (abstr. 41).
12. Wagner JE, Vogelsang GB, Zehnbauer BA et al. Relapse of leukemia after bone marrow transplantation: effect of second myeloablative therapy. Bone Marrow Transplant 1992; 9: 205-209.
13. Cullis JO, Schwarer AP, Hughes TP et al. Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioning. Br J Haematol 1992; 80: 33-39.
14. Mrsic M, Horowitz MM, Atkinson K et al. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 1992; 9: 269-275.
15. Shing MMK, Vowels M. Role of second bone marrow transplants. Bone Marrow Transplant 1993; 12: 21-25.
16. Radich JP, Sanders JE, Buckner CD et al. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. J Clin Oncol 1993; 11: 304-313.
17. Blazar BR, Orr H, Arthur D et al. Restriction fragment length polymorphism as markers of engraftment in allogeneic marrow transplantation. Blood 1985; 66: 1436-1444.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Star Assoc 1958, 53: 457-481.
19. Mortimer J, Blinder MA, Schulman S et al. Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy. J Clin Oncol 1989; 7: 50-57.
20. Lalit K. Leukemia: management of relapse after allogeneic bone marrow transplantation. J Clin Oncol 1994; 12: 1710-1717.
21. Giralt SA, Champlin RE. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 1994; 84: 3603-3612.
22. Kolb HJ, Mittermuller J, Clemm C et al. Donor leukocyte transfusion for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.